For: | Meireles LC, Marinho RT, Van Damme P. Three decades of hepatitis B control with vaccination. World J Hepatol 2015; 7(18): 2127-2132 [PMID: 26328023 DOI: 10.4254/wjh.v7.i18.2127] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v7/i18/2127.htm |
Number | Citing Articles |
1 |
Casey P. Shannon, Travis M. Blimkie, Rym Ben-Othman, Nicole Gladish, Nelly Amenyogbe, Sibyl Drissler, Rachel D. Edgar, Queenie Chan, Mel Krajden, Leonard J. Foster, Michael S. Kobor, William W. Mohn, Ryan R. Brinkman, Kim-Anh Le Cao, Richard H. Scheuermann, Scott J. Tebbutt, Robert E.W. Hancock, Wayne C. Koff, Tobias R. Kollmann, Manish Sadarangani, Amy Huei-Yi Lee. Multi-Omic Data Integration Allows Baseline Immune Signatures to Predict Hepatitis B Vaccine Response in a Small Cohort. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.578801
|
2 |
Neta S. Zuckerman, Lester M. Shulman. Encyclopedia of Sustainability Science and Technology. 2020; : 1 doi: 10.1007/978-1-4939-2493-6_1090-1
|
3 |
Eric W. Chak, Souvik Sarkar, Christopher Bowlus. Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis. Digestive Diseases and Sciences 2016; 61(10): 2776 doi: 10.1007/s10620-016-4205-3
|
4 |
Baruch Velan, Yaacov Yadgar. On the implications of desexualizing vaccines against sexually transmitted diseases: health policy challenges in a multicultural society. Israel Journal of Health Policy Research 2017; 6(1) doi: 10.1186/s13584-017-0153-4
|
5 |
Chinwe Lucia Ochu, Caryl M Beynon. Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high risk public safety workers in Kaduna State, Nigeria: a cross sectional survey. BMJ Open 2017; 7(5): e015845 doi: 10.1136/bmjopen-2017-015845
|
6 |
Nori Yoshioka, Matsuo Deguchi, Hideharu Hagiya, Masanori Kagita, Hiroko Tsukamoto, Miyuki Takao, Hisao Yoshida, Norihisa Yamamoto, Yukihiro Akeda, Yoshiko Nabetani, Ikuhiro Maeda, Yoh Hidaka, Kazunori Tomono, Jason Blackard. Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations. PLOS ONE 2017; 12(11): e0187661 doi: 10.1371/journal.pone.0187661
|
7 |
Sen Yuan, Yousaf Tanzeel, Xuezhang Tian, Dandan Zheng, Naz Wajeeha, Jiaqi Xu, Yujia Ke, Zuopeng Zhang, Xiaojun Peng, Long Lu, Guihong Sun, Deyin Guo, Min Wang. Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00588-3
|
8 |
Pierre Van Damme, Marc Dionne, Geert Leroux‐Roels, Olivier Van Der Meeren, Emmanuel Di Paolo, Bruno Salaun, Pemmaraju Surya Kiran, Nicolas Folschweiller. Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults. Journal of Viral Hepatitis 2019; 26(9): 1066 doi: 10.1111/jvh.13125
|
9 |
Katrina A B Goddard, Eric J Feuer, Asad Umar, Philip E Castle. Accelerating progress to reduce the cancer burden through prevention and control in the United States. JNCI: Journal of the National Cancer Institute 2024; doi: 10.1093/jnci/djae204
|
10 |
Monica L. Kasting, Katharine J. Head, Dena Cox, Anthony D. Cox, Gregory D. Zimet. The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trial. Preventive Medicine 2019; 127: 105798 doi: 10.1016/j.ypmed.2019.105798
|
11 |
Sanjit Boora, Vikrant Sharma, Sulochana Kaushik, Ajoy Varma Bhupatiraju, Sandeep Singh, Samander Kaushik. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Brazilian Journal of Microbiology 2023; 54(2): 679 doi: 10.1007/s42770-023-00970-y
|
12 |
Chris Huynh, Gerald Y. Minuk, Julia Uhanova, Maureen Baikie, Thomas Wong, Carla Osiowy. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada. Vaccine 2017; 35(35): 4515 doi: 10.1016/j.vaccine.2017.07.040
|
13 |
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Paolo Leandri, Elisabetta Loggi, Pietro Andreone. Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis. World Journal of Hepatology 2017; 9(6): 333-342 doi: 10.4254/wjh.v9.i6.333
|
14 |
Sandra Bivegete, Anna L McNaughton, Adam Trickey, Zak Thornton, Becky Scanlan, Aaron G Lim, Lina Nerlander, Hannah Fraser, Josephine G Walker, Matthew Hickman, Peter Vickerman, Helen Johnson, Erika Duffell, Ellen Brooks-Pollock, Hannah Christensen. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review.
Eurosurveillance 2023; 28(30) doi: 10.2807/1560-7917.ES.2023.28.30.2200738
|
15 |
Karima Abounouh, Ahd Ouladlahsen, Haya Altawalah, Ali A. Rabaan, Hind Dehbi, Fadila Guessous, Sayeh Ezzikouri. Advances in Antiviral Research. Livestock Diseases and Management 2024; : 393 doi: 10.1007/978-981-99-9195-2_16
|
16 |
Lloyd D.W. King, David Pulido, Jordan R. Barrett, Hannah Davies, Doris Quinkert, Amelia M. Lias, Sarah E. Silk, David J. Pattinson, Ababacar Diouf, Barnabas G. Williams, Kirsty McHugh, Ana Rodrigues, Cassandra A. Rigby, Veronica Strazza, Jonathan Suurbaar, Chloe Rees-Spear, Rebecca A. Dabbs, Andrew S. Ishizuka, Yu Zhou, Gaurav Gupta, Jing Jin, Yuanyuan Li, Cecilia Carnrot, Angela M. Minassian, Ivan Campeotto, Sarel J. Fleishman, Amy R. Noe, Randall S. MacGill, C. Richter King, Ashley J. Birkett, Lorraine A. Soisson, Carole A. Long, Kazutoyo Miura, Rebecca Ashfield, Katherine Skinner, Mark R. Howarth, Sumi Biswas, Simon J. Draper. Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies. Cell Reports Medicine 2024; 5(7): 101654 doi: 10.1016/j.xcrm.2024.101654
|
17 |
Mawuena Binka, Zahid A Butt, Stanley Wong, Mei Chong, Jane A Buxton, Nuria Chapinal, Amanda Yu, Maria Alvarez, Maryam Darvishian, Jason Wong, Gina McGowan, Mikhail Torban, Mark Gilbert, Mark Tyndall, Mel Krajden, Naveed Z Janjua. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada. World Journal of Gastroenterology 2018; 24(11): 1216-1227 doi: 10.3748/wjg.v24.i11.1216
|
18 |
Rodas Temesgen Annose, Abdulsemed Mohammed Nur, Abel Zemenfes Tsige, Leja Hamza Juhar, Arsema Goytom Zegergsh. Hepatitis B vaccination status among patients with end-stage kidney disease on haemodialysis in Ethiopia: a multi-center cross-sectional study. BMC Nephrology 2024; 25(1) doi: 10.1186/s12882-024-03703-x
|
19 |
Andrea Rasche, Breno Frederico de Carvalho Dominguez Souza, Jan Felix Drexler. Bat hepadnaviruses and the origins of primate hepatitis B viruses. Current Opinion in Virology 2016; 16: 86 doi: 10.1016/j.coviro.2016.01.015
|
20 |
Joelma Goetz de Gois, Sthefanny Josephine Klein Ottoni Guedes, Ana Paula Vieira, Franciele Aní Caovilla Follador, Luís Fernando Dip, Léia Carolina Lucio, Kérley Braga Pereira Bento Casaril, Paulo Cezar Nunes Fortes, Valdir Spada Júnior, Guilherme Welter Wendt, Lirane Elize Defante Ferreto, Jason T. Blackard. Seroprevalence and factors associated with hepatitis B virus exposure in the incarcerated population from southern Brazil. PLOS ONE 2022; 17(11): e0278029 doi: 10.1371/journal.pone.0278029
|
21 |
Catherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, Victoria Giffin, Abishek Chandrashekar, Amanda J. Martinot, Tochi Anioke, Olivia C. Powers, Kevin Hall, David Hope, Jessica Miller, Nichole P. Hachmann, Benjamin Chung, Sarah Gardner, Daniel Sellers, Julia Barrett, Mark G. Lewis, Hanne Andersen, Harry Kleanthous, Ki-Woen Seo, Su Jeen Lee, Yong Wook Park, Hun Kim, Dan H. Barouch. Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques. npj Vaccines 2023; 8(1) doi: 10.1038/s41541-023-00622-0
|
22 |
Justin Lee, Benjamin R. Uy, Linda M. Liau. Brain Tumor Vaccines. Neurosurgery Clinics of North America 2021; 32(2): 225 doi: 10.1016/j.nec.2021.01.003
|
23 |
Parker Elijah Joshua, Cynthia Ogochukwu Nwauzor, Damian Chukwu Odimegwu, Uzochukwu Gospel Ukachukwu, Rita Onyekachukwu Asomadu, Timothy Prince Chidike Ezeorba, Isabelle Chemin. Experimental and molecular predictions of the adjuvanticity of snail mucin on hepatitis B vaccine in albino mice. PLOS ONE 2021; 16(7): e0246915 doi: 10.1371/journal.pone.0246915
|
24 |
Zhao X. Hu, Yi N. Ye, Wei G. Wu, Xu J. Liang, Qi W. Wu, Ao Zhang, Xing R. Zheng, Zhi L. Gao, Liang Peng, Chan Xie. Real-Life State of Anti-Hepatitis B Virus Drug Choice in Child-Bearing Age Male Patients and Effect on Fertility and Fetal Safety. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/9703907
|
25 |
Neda Kabiri, Rahim Khodayari-zarnaq, Manouchehr Khoshbaten, Ali Janati. Gastrointestinal Cancer Prevention Policies. International Journal of Preventive Medicine 2022; 13(1): 8 doi: 10.4103/ijpvm.IJPVM_419_20
|
26 |
Tulgaa Lonjid, Ganchimeg Dondov, Tegshjargal Badamjav, Batbold Batsaikhan, Batsukh Badamnachin, Gantogtokh Dashjamts, Chinbayar Tserendorj, Bilegtsaikhan Tsolmon. The Dynamics of the Prevalence of Acute Viral Hepatitis and the Strategies against Viral Hepatitis in Mongolia. Euroasian journal of hepato-gastroenterology 2024; 14(1): 65 doi: 10.5005/jp-journals-10018-1435
|
27 |
Christine E. Gilmartin, Andrew J. Daley, Laura Leung. The hepatitis B birth‐dose immunisation: Exploring parental refusal. Australian and New Zealand Journal of Obstetrics and Gynaecology 2020; 60(1): 93 doi: 10.1111/ajo.13008
|
28 |
Daniel Castaneda, Adalberto Jose Gonzalez, Mohammad Alomari, Kanwarpreet Tandon, Xaralambos Bobby Zervos. From hepatitis A to E: A critical review of viral hepatitis. World Journal of Gastroenterology 2021; 27(16): 1691-1715 doi: 10.3748/wjg.v27.i16.1691
|
29 |
Katharine Valéria Saraiva Hodel, Bianca Sampaio Dotto Fiuza, Rodrigo Souza Conceição, Augusto Cezar Magalhães Aleluia, Thassila Nogueira Pitanga, Larissa Moraes dos Santos Fonseca, Camila Oliveira Valente, Cintia Silva Minafra-Rezende, Bruna Aparecida Souza Machado. Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review. Pharmaceuticals 2024; 17(6): 807 doi: 10.3390/ph17060807
|
30 |
Micah Oyaro, John Wylie, Chien-Yu Chen, Raphael O. Ondondo, Anna Kramvis. Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities. Southern African Journal of HIV Medicine 2018; 19(1) doi: 10.4102/sajhivmed.v19i1.737
|
31 |
Maria Francesca Armentano, Marianna Caterino, Rocchina Miglionico, Angela Ostuni, Maria Carmela Pace, Flora Cozzolino, Maria Monti, Luigi Milella, Monica Carmosino, Piero Pucci, Faustino Bisaccia. New insights on the functional role of URG7 in the cellular response to ER stress. Biology of the Cell 2018; 110(7): 147 doi: 10.1111/boc.201800004
|
32 |
Babayemi O. Olakunde, Ijeoma M. Ifeorah, Daniel A. Adeyinka, Olubunmi A. Olakunde, Temitayo Ogundipe, John O. Olawepo, Echezona E. Ezeanolue. Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis. Tropical Medicine and Health 2024; 52(1) doi: 10.1186/s41182-024-00594-4
|
33 |
Albashir Tahir, Sa’adatu Haruna Shinkafi, Ahmed Subeh Alshrari, Abdulmajeed Yunusa, Muhammad Tukur Umar, Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh. A Comprehensive Review of Hepatitis B Vaccine Nonresponse and Associated Risk Factors. Vaccines 2024; 12(7): 710 doi: 10.3390/vaccines12070710
|
34 |
Ruksana Raihan, Sheikh Mohammad Fazle Akbar, Musarrat Mahtab, Sajib Chakraborty, Rajib Chakravorty, Saruar Alam, Yearul Kabir, Md Atikul Islam, Md Abul Khair Yusuf. A Dynamic Mathematical Modeling Revelation about the Impact of Vaccination on Hepatitis B Virus-induced Infection and Death Rate in Bangladesh
. Euroasian Journal of Hepato-Gastroenterology 2019; 9(2): 84 doi: 10.5005/jp-journals-10018-1303
|
35 |
Shelina Moonsamy, Pavitra Pillay, Nishi Prabdial-Sing, Abram L. Wagner. Hepatitis B infection status among South Africans attending public health facilities over a five-year period: 2015 to 2019. PLOS Global Public Health 2023; 3(9): e0000992 doi: 10.1371/journal.pgph.0000992
|
36 |
Alberto Enrico Maraolo, Ivan Gentile, Antonio Riccardo Buonomo, Biagio Pinchera, Guglielmo Borgia. Current evidence on the management of hepatitis B in pregnancy. World Journal of Hepatology 2018; 10(9): 585-594 doi: 10.4254/wjh.v10.i9.585
|
37 |
Aswin Damodaran, Subin Mary Zachariah, Sreeja Chandrasekharan Nair. Novel Therapeutic Approaches for the Management of Hepatitis Infections. Therapeutic Delivery 2024; 15(3): 211 doi: 10.4155/tde-2023-0074
|
38 |
Greta A Kilmer, Laurie K Barker, Kathleen N Ly, Ruth B Jiles. Hepatitis B Vaccination and Screening Among Foreign-born Women of Reproductive Age in the United States: 2013–2015. Clinical Infectious Diseases 2019; 68(2): 256 doi: 10.1093/cid/ciy479
|
39 |
Akwasi Adjei Gyimah, Prince Peprah, Williams Agyemang-Duah, Eric Frimpong, Ariel Kwegyir Tsiboe, Mercy Aboagye Darkwa, Tsai-Ching Hsu. Hepatitis B vaccination status and associated factors among university students in Ghana: A cross-sectional survey. Cogent Medicine 2021; 8(1) doi: 10.1080/2331205X.2021.2005226
|
40 |
Litao Zheng. Analysis of hepatocellular carcinoma associated with hepatitis B virus. Journal of Cellular and Molecular Medicine 2023; 27(16): 2271 doi: 10.1111/jcmm.17867
|
41 |
Said A. Al-Busafi, Ahmed Alwassief. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030. Vaccines 2024; 12(3): 288 doi: 10.3390/vaccines12030288
|
42 |
Fuzhen Wang, Guomin Zhang, Hui Zheng, Ning Miao, Liping Shen, Feng Wang, Pumei Dong, Fei Du, Chao Chen, Xiaoshu Zhang, Fuqiang Cui. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. Vaccine 2017; 35(33): 4229 doi: 10.1016/j.vaccine.2017.06.019
|
43 |
Maria Zahid, Ursula Rinas. Recombinant Protein Production in Yeast. Methods in Molecular Biology 2019; 1923: 309 doi: 10.1007/978-1-4939-9024-5_14
|
44 |
Sindhu Vikash, Fnu Vikash, Aarushi Sudan, Bisrat Adal, Donald Kotler. Addressing Barriers to Care in Hepatocellular Carcinoma: Promoting Equity and Access. Cureus 2023; doi: 10.7759/cureus.41893
|
45 |
Tatyana Kushner, Richard R. Andrews. Addressing hepatitis delta in primary care practices in the US: a narrative review. Current Medical Research and Opinion 2024; 40(5): 813 doi: 10.1080/03007995.2024.2318004
|
46 |
Sarwo Handayani, Frans Dany. Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022). 2023; : 220 doi: 10.2991/978-94-6463-112-8_22
|
47 |
Rachel A. Smith, Curtis Bone, Ashley Visco, William A. Calo, Jessica Wright, Destin Groff, Robert P. Lennon. Skeptical Health Mavens May Limit COVID-19 Vaccine Diffusion: Using the Innovation Diffusion Cycle to Interpret Results of a Cross-sectional Survey among People Who are Socially Vulnerable. Journal of Health Communication 2022; 27(6): 375 doi: 10.1080/10810730.2022.2111619
|
48 |
Alekhya Penumarthi, Peter M Smooker. New approaches to VLP-based vaccines. Microbiology Australia 2017; 38(2): 93 doi: 10.1071/MA17038
|
49 |
Teresa Pollicino, Cristina Musolino, Natasha Irrera, Alessandra Bitto, Daniele Lombardo, Martina Timmoneri, Letteria Minutoli, Giovanni Raimondo, Giovanni Squadrito, Francesco Squadrito, Domenica Altavilla. Flavocoxid exerts a potent antiviral effect against hepatitis B virus. Inflammation Research 2018; 67(1): 89 doi: 10.1007/s00011-017-1099-2
|
50 |
Wim Van Hooste. To boost or not to boost? The long-term protection of people vaccinated in infancy from the perspective of the healthcare worker. Infectious Diseases 2020; 52(9): 678 doi: 10.1080/23744235.2020.1780308
|
51 |
Ali A. Alali, Mahmoud N. Abo-Shehada. Prevalence of Hepatitis B Virus infection in the Gulf Cooperation Council: a systematic review and meta-analysis. BMC Infectious Diseases 2022; 22(1) doi: 10.1186/s12879-022-07806-4
|
52 |
He Zhang, Yumi Itoh, Tatsuya Suzuki, Kan‐ichiro Ihara, Tomohisa Tanaka, Saori Haga, Hajime Enatsu, Maho Yumiya, Mari Kimura, Akira Takada, Daiki Itoh, Yuri Shibazaki, Shuto Nakao, Sachiyo Yoshio, Kei Miyakawa, Yuki Miyamoto, Hanae Sasaki, Tadahiro Kajita, Masaya Sugiyama, Masashi Mizokami, Taro Tachibana, Akihide Ryo, Kohji Moriishi, Eiji Miyoshi, Tatsuya Kanto, Toru Okamoto, Yoshiharu Matsuura. Establishment of monoclonal antibodies broadly neutralize infection of hepatitis B virus. Microbiology and Immunology 2022; 66(4): 179 doi: 10.1111/1348-0421.12964
|
53 |
Helen Swede, Dejana Braithwaite. Adipocytokines, Energy Balance, and Cancer. Energy Balance and Cancer 2017; 12: 235 doi: 10.1007/978-3-319-41677-9_10
|
54 |
H. LI, G. J. LI, Q. Y. CHEN, Z. L. FANG, X. Y. WANG, C. TAN, Q. L. YANG, F. Z. WANG, F. WANG, S. ZHANG, S. L. BI, L. P. SHEN. Long-term effectiveness of plasma-derived hepatitis B vaccine 22–28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?. Epidemiology and Infection 2017; 145(5): 887 doi: 10.1017/S0950268816003046
|
55 |
Seroprevalence of anti-HBs antibodies and the need for booster vaccination in children under 5 years of age born to HBsAg-negative mothers. Asian Pacific Journal of Tropical Medicine 2021; 14(9): 410 doi: 10.4103/1995-7645.326255
|
56 |
Mekuanint Geta, Endalew Yizengaw, Tsegahun Manyazewal. Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis. BMC Pediatrics 2024; 24(1) doi: 10.1186/s12887-024-04557-w
|
57 |
Saibal Das, Kirubakaran Ramakrishnan, Sapan Kumar Behera, Mahalakshmi Ganesapandian, Alphienes Stanley Xavier, Sandhiya Selvarajan. Hepatitis B Vaccine and Immunoglobulin: Key Concepts. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00037
|
58 |
Guglielmo Bove, Ann-Kathrin Mehnert, Viet Loan Dao Thi. iPSCs for Studying Infectious Diseases. 2021; : 149 doi: 10.1016/B978-0-12-823808-0.00013-4
|
59 |
George Elias, Pieter Meysman, Esther Bartholomeus, Nicolas De Neuter, Nina Keersmaekers, Arvid Suls, Hilde Jansens, Aisha Souquette, Hans De Reu, Marie-Paule Emonds, Evelien Smits, Eva Lion, Paul G Thomas, Geert Mortier, Pierre Van Damme, Philippe Beutels, Kris Laukens, Viggo Van Tendeloo, Benson Ogunjimi. Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination. eLife 2022; 11 doi: 10.7554/eLife.68388
|
60 |
A. Riccomi, C. M. Trombetta, M. Dorrucci, D. Di Placido, N. Sanarico, F. Farchi, R. Giuseppetti, U. Villano, C. Marcantonio, S. Marchi, A. Ciaramella, P. Pezzotti, E. Montomoli, C. Valdarchi, A. R. Ciccaglione, S. Vendetti. Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination. Vaccines 2024; 12(4): 425 doi: 10.3390/vaccines12040425
|
61 |
Florian Bert, Andreas Rindermann, Murad A. Abdelfattah, Jona T. Stahmeyer, Siegbert Rossol. High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit. European Journal of Gastroenterology & Hepatology 2016; 28(11): 1246 doi: 10.1097/MEG.0000000000000702
|
62 |
Eui Gwon Hwang, Eun-Ae Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim. Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis. Hepatology International 2023; 17(4): 860 doi: 10.1007/s12072-023-10528-7
|
63 |
Sheikh MF Akbar, Mamun Al-Mahtab, Sakirul I Khan, Ananta Shrestha, Shahina Tabassum, Yoichi Hiasa. Current Trends in Hepatitis B Vaccination. Future Virology 2016; 11(5): 369 doi: 10.2217/fvl-2016-0025
|
64 |
Mahsa Eshkevar Vakili, Niloofar Mashhadi, Mohammad Reza Ataollahi, Seppo Meri, Dieter Kabelitz, Kurosh Kalantar. Hepatitis B vaccine responders show higher frequencies of CD8+ effector memory and central memory T cells compared to non‐responders. Scandinavian Journal of Immunology 2024; 100(5) doi: 10.1111/sji.13402
|
65 |
E. Okeke, P. Mark Davwar, B. Mullen, M. Duguru, O. Agbaji, A. Sagay, R. Murphy, C. Hawkins. The impact of HIV on hepatocellular cancer survival in Nigeria. Tropical Medicine & International Health 2021; 26(3): 335 doi: 10.1111/tmi.13532
|
66 |
Jonathan D Alpern, Heesoo Joo, Nathan C Bahr, Thomas M Leventhal. Factors Associated With Adherence to First-line Antiviral Therapy Among Commercially Insured Patients With Chronic Hepatitis B. Open Forum Infectious Diseases 2023; 10(3) doi: 10.1093/ofid/ofad118
|
67 |
Özgür M. Koc, Eva van Oorschot, Lloyd Brandts, Astrid Oude Lashof. Timing of primary three‐dose hepatitis B vaccination and postvaccination serologic testing among a large cohort of healthy adults. Journal of Medical Virology 2022; 94(9): 4433 doi: 10.1002/jmv.27848
|
68 |
Samuel Amoah, Andrew Nicholas Yartey, Praise Fosu Adjei, Margaret Owusu-Akyaw, Joseph Boachie, David Larbi Simpong, Patrick Adu, Gianpiero Greco. HBV Infection Is an Intermediate‐Risk Disease, Whereas Anaemia Is a Mild‐to‐Moderate Public Health Problem in Young Ghanaian Adults: A Four‐Year Retrospective Analysis of Students’ Medical Records. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/9318984
|
69 |
Titilayo Kemi Sophia Nelly ADEDJOBI, Daniel Kariuki, James Kimotho. Co-administration of a Hepatitis B vaccine with CpG-ODN 2395 induces stronger immune response in BALB/c mice. F1000Research 2024; 13: 404 doi: 10.12688/f1000research.145766.1
|
70 |
Xinlei Li, Zhaohui Xu, Bidisha Mitra, Minghang Wang, Haitao Guo, Zongdi Feng. Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00641-1
|
71 |
Grace Naswa Makokha, Peiyi Zhang, C. Nelson Hayes, Elijah Songok, Kazuaki Chayama. The burden of Hepatitis B virus infection in Kenya: A systematic review and meta-analysis. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.986020
|
72 |
Neta S. Zuckerman, Lester M. Shulman. Infectious Diseases. Encyclopedia of Sustainability Science and Technology Series 2023; : 35 doi: 10.1007/978-1-0716-2463-0_1090
|
73 |
Philippa White, Kate O'Donnell, Aline Brennan, Martin Davoren, Fiona Lyons, Mick Quinlan, Bill Foley, Caroline Hurley, Derval Igoe, Peter Barrett. Hepatitis A and B vaccination in gbMSM in Ireland: findings from the European MSM Internet Survey 2017 (EMIS-2017). Sexually Transmitted Infections 2023; 99(5): 337 doi: 10.1136/sextrans-2022-055580
|
74 |
Arianna Marini, Yu Zhou, Yuanyuan Li, Iona J. Taylor, Darren B. Leneghan, Jing Jin, Marija Zaric, David Mekhaiel, Carole A. Long, Kazutoyo Miura, Sumi Biswas. A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02931
|
75 |
Habiba Kamal, Romina Fornes, Johanna Simin, Per Stål, Ann‐Sofi Duberg, Nele Brusselaers, Soo Aleman. Risk of hepatocellular carcinoma in hepatitis B and D virus co‐infected patients: A systematic review and meta‐analysis of longitudinal studies. Journal of Viral Hepatitis 2021; 28(10): 1431 doi: 10.1111/jvh.13577
|
76 |
Lucile Dumolard, Caroline Aspord, Patrice N. Marche, Zuzana Macek Jilkova. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1148111
|
77 |
Anli Yang, Zhiyong Guo, Qingqi Ren, Linwei Wu, Yi Ma, Anbin Hu, Dongping Wang, Haidan Ye, Xiaofeng Zhu, Weiqiang Ju, Xiaoshun He, Do Young Kim. Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study. PLOS ONE 2017; 12(11): e0188190 doi: 10.1371/journal.pone.0188190
|
78 |
James Clark-Wright, Pollyanna Hudson, Conor McCloskey, Stuart Carroll. Burden of Selected Infectious Diseases Covered by UK Childhood Vaccinations: Systematic Literature Review. Future Microbiology 2020; 15(17): 1679 doi: 10.2217/fmb-2020-0170
|
79 |
Hussein Abdellatif. Circulating CD34+ hematopoietic stem/progenitor cells paralleled with level of viremia in patients chronically infected with hepatitis B virus. Regenerative Medicine Research 2018; 6: 1 doi: 10.1051/rmr/170005
|
80 |
Jin-yu Yang, Min Li, Cheng-liang Zhang, Dong Liu. Pharmacological properties of baicalin on liver diseases: a narrative review. Pharmacological Reports 2021; 73(5): 1230 doi: 10.1007/s43440-021-00227-1
|
81 |
Kwadwo Asamoah Kusi, William van der Puije, Diana A. Asandem, Rawdat Baba-Adam, Hardy Agbevey, Bright Asare, Philip Segbefia, Lutterodt Bentum-Ennin, Audrey Annan, Frank Osei, Doreen Teye-Adjei, Elsie Sutaya Galevo, Gifty Odame, Gloria Ansa, Linda Amoah, Joseph Humphrey Kofi Bonney. World Hepatitis day 2021 –screening and vaccination against Hepatitis B virus in Accra, Ghana. BMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-16108-6
|
82 |
N. Scherbaum, J. Timm, F. Richter, U. Bonnet, J. Bombeck, S. Lajos, M. Specka. Outcome of a hepatitis B vaccination program for clients of a drug consumption facility. Journal of Clinical Virology 2018; 106: 28 doi: 10.1016/j.jcv.2018.04.014
|
83 |
Kaeli N. Heidenreich, Shannon Blair, Hayley Gillespie, Amanda J. Chang, James L. Burns, Malika D. Shah. Hepatitis B Birth Dose Vaccination Improvement Initiative. Advances in Neonatal Care 2024; 24(3): 237 doi: 10.1097/ANC.0000000000001169
|
84 |
Xue Chen, Ann M. Bode, Zigang Dong, Ya Cao. The epithelial–mesenchymal transition (EMT) is regulated by oncoviruses in cancer. The FASEB Journal 2016; 30(9): 3001 doi: 10.1096/fj.201600388R
|
85 |
Ridhwaanah Jacobs, Makafui Dennis Dogbey, Njabulo Mnyandu, Keila Neves, Stefan Barth, Patrick Arbuthnot, Mohube Betty Maepa. AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy. Microorganisms 2023; 11(12): 2985 doi: 10.3390/microorganisms11122985
|
86 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do. Liver Research 2024; 8(2): 83 doi: 10.1016/j.livres.2024.05.004
|